Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study

被引:0
|
作者
Savard, Josee [1 ,2 ,3 ,8 ]
Filion, Catherine [2 ,3 ]
Brearty, Claudia Mc [1 ,2 ,3 ]
Caplette-Gingras, Aude [2 ,4 ]
Chiquette, Jocelyne [2 ,4 ,5 ]
Dorval, Michel [3 ,6 ,7 ]
机构
[1] Univ Laval, Sch Psychol, Quebec City, PQ, Canada
[2] Univ Laval, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada
[3] Univ Laval, Canc Res Ctr, Quebec City, PQ, Canada
[4] Univ Laval, CHU Quebec, Ctr Maladies Sein, Quebec City, PQ, Canada
[5] Univ Laval, Fac Med, Quebec City, PQ, Canada
[6] Univ Laval, Fac Pharm, Quebec City, PQ, Canada
[7] CISSS Chaudiere Appalaches Res Ctr, Levis, PQ, Canada
[8] Univ Laval, Hop Enfant Jesus, Ctr integre cancerol, CHU Quebec, 1401 18e Rue, Quebec City, PQ G1J 1Z4, Canada
来源
CANCER MEDICINE | 2024年 / 13卷 / 01期
关键词
BRCA1/2 genetic mutation; breast cancer; fear of cancer recurrence; psychological intervention; qualitative study; RISK REDUCTION; THERAPY;
D O I
10.1002/cam4.6889
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThere is preliminary evidence suggesting that FCR is a major problem for breast cancer survivors carrying a BRCA1/2 mutation. The goal of this qualitative study, conducted among women who were treated for breast cancer, was to provide a deeper understanding of how FCR is experienced in the context of a genetic predisposition to breast cancer.MethodThree focus groups (90-110 min) were conducted with 19 breast cancer survivors carrying a BRCA1/2 mutation. The semistructured interview probed FCR level and impact, the role FCR played in the decision to have a prophylactic bilateral mastectomy and/or salpingo-oophorectomy, the effect that surgery had on FCR, and the relevance of offering a psychological intervention targeting FCR to this population.ResultsFindings indicated that FCR was a significant issue in these women, even though a majority had undergone a prophylactic surgery. Patients strongly affirmed the need to develop and provide access to FCR interventions that are specifically adapted to the needs of this group.DiscussionThese results suggest that, although being the most effective medical option to reduce the actual risk of local recurrence (or second breast cancer), prophylactic surgery only partially reduces FCR. A psychological intervention targeting specifically FCR would be an appropriate complement to preventive surgery.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Pregnancy after breast cancer in BRCA1/2 mutation carriers
    Maksimenko, Jelena
    Irmejs, Arvids
    Gardovskis, Janis
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2022, 20 (01)
  • [32] Conservative Management of Breast Cancer in BRCA1/2 Mutation Carriers
    Garcia-Etienne, C. A.
    Barile, M.
    Gentilini, O. D.
    Botteri, E.
    Rotmensz, N.
    Farante, G.
    Luini, A.
    Bonanni, B.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 3 - 4
  • [33] BRCA1 and BRCA2 mutation screening in sporadic and familial breast cancer
    Ellis, D
    McCall, SH
    Greenman, J
    Evans, G
    Abbs, S
    Hodgson, SV
    Mathew, CG
    JOURNAL OF MEDICAL GENETICS, 1999, 36 : S38 - S38
  • [34] Compliance With Tamoxifen in Women With Breast Cancer and a BRCA1 or BRCA2 Mutation
    Narod, Steven A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) : E698 - E699
  • [35] Aspirin and breast cancer risk for BRCA1 and BRCA2 mutation carriers
    Kornhauser, Naomi
    Terry, Mary Beth
    Vahdat, Linda T.
    Andrulis, Irene
    Buys, Saundra
    Daly, Mary
    John, Esther
    Hopper, John L.
    Cigler, Tessa
    CANCER RESEARCH, 2015, 75
  • [36] BRCA1 and BRCA2 mutation screening in breast cancer families.
    Phelan, CM
    Lancaster, JM
    Gumbs, C
    de los Rios, P
    Abrahamson, J
    Warner, E
    Parfrey, NA
    Futreal, PA
    Narod, SA
    BRITISH JOURNAL OF CANCER, 1998, 78 : 12 - 12
  • [37] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    K Metcalfe
    S Gershman
    H T Lynch
    P Ghadirian
    N Tung
    C Kim-Sing
    O I Olopade
    S Domchek
    J McLennan
    A Eisen
    W D Foulkes
    B Rosen
    P Sun
    S A Narod
    British Journal of Cancer, 2011, 104 : 1384 - 1392
  • [38] Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population
    Friedman, LS
    Gayther, SA
    Kurosaki, T
    Gordon, D
    Noble, B
    Casey, G
    Ponder, BAJ
    AntonCulver, H
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (02) : 313 - 319
  • [39] Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    M Ahmed
    F Lalloo
    A Howell
    DG Evans
    Breast Cancer Research, 12
  • [40] Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos
    Jan Lubinski
    Leonardo Salmena
    Henry T Lynch
    Charmaine Kim-Sing
    William D Foulkes
    Parviz Ghadirian
    Susan L Neuhausen
    Rochelle Demsky
    Nadine Tung
    Peter Ainsworth
    Leigha Senter
    Andrea Eisen
    Charis Eng
    Christian Singer
    Ophira Ginsburg
    Joanne Blum
    Tomasz Huzarski
    Aletta Poll
    Ping Sun
    Steven A Narod
    Breast Cancer Research, 14